In February 2018, Riverside Capital investors purchased a forward funding opportunity to construct a purpose-built Research and Development (R&D) facility in Ely, Cambridgeshire. The development, once completed, will comprise approx. 37,500 sq. ft. of research laboratories, manufacturing, warehousing and office space to be occupied by Cambridge Nutritional Sciences Ltd (“CNS”). The tenant has agreed a 25 year lease, reviewed every five years and linked to the Retail Price Index (“RPI”) between 2% and 5%. CNS will initially be paying £595,000.00 p.a. from the date of occupation.
- Purchase date 02/2018
- Purchase price £8.75
- Net Initial Yield (once income producing) 6.60%